Patent · US Active

Methods of evaluating immunogenicity of an agent using an artificial tissue construct

US10731129B2 · kind B2 · utility

1Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2013
Grant dateAug 4, 2020
Priority date
Expiry dateJun 15, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Artificial tissue constructs (TCs), methods of making the TCs, uses thereof, and kits comprising the TCs are provided. TCs are useful for vaccine evaluation for human adult, human non-newborn, and newborns.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.